These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

153 related articles for article (PubMed ID: 32057636)

  • 1. Myasthenia gravis after etanercept and ustekinumab treatment for psoriatic arthritis: A case report.
    Nicocia G; Bonanno C; Lupica A; Toscano A; Rodolico C
    Neuromuscul Disord; 2020 Mar; 30(3):246-249. PubMed ID: 32057636
    [TBL] [Abstract][Full Text] [Related]  

  • 2. How effective is ustekinumab in controlling psoriatic arthritis?
    Bonifati C; Graceffa D
    Dermatol Ther; 2016 May; 29(3):155-9. PubMed ID: 26626908
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Myasthenia gravis onset during rheumatic disease: a new paradoxical effect of anti-TNF alpha therapy?
    Bruzzese V; Marrese C; Scolieri P; Hassan C; Lorenzetti R; Zullo A
    Int J Rheum Dis; 2015 Mar; 18(3):375-6. PubMed ID: 24702703
    [No Abstract]   [Full Text] [Related]  

  • 4. Myasthenia gravis associated with etanercept therapy.
    Fee DB; Kasarskis EJ
    Muscle Nerve; 2009 Jun; 39(6):866-70. PubMed ID: 19373885
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Thymoma Showing Elevating Anti-acetylcholine Receptor Antibody without Clinical Symptoms of Myasthenia Gravis;Report of a Case].
    Ito T; Ishizumi T; Kataba H; Saijo T; Ikeda N
    Kyobu Geka; 2018 Aug; 71(8):634-636. PubMed ID: 30185764
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Worsening of Psoriatic Arthritis After Ustekinumab Treatment.
    Onsun N; Yalcin B; Sallahoglu K; Rezvani A
    Am J Ther; 2018; 25(3):e381-e382. PubMed ID: 29189317
    [No Abstract]   [Full Text] [Related]  

  • 7. Thymoma-associated myasthenia gravis without acetylcholine receptor antibodies.
    Rigamonti A; Lauria G; Piamarta F; Fiumani A; Agostoni E
    J Neurol Sci; 2011 Mar; 302(1-2):112-3. PubMed ID: 21236448
    [TBL] [Abstract][Full Text] [Related]  

  • 8. The Paradoxical Induction of Crohn’s Disease Following Treatment of Psoriatic Arthritis With Etanercept.
    Forouzandeh M; Vazquez T; Nouri K; Forouzandeh B
    J Drugs Dermatol; 2019 Aug; 18(8):832-834. PubMed ID: 31424717
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Ustekinumab associated chronic eosinophilic pneumonia.
    Kalra SS; Chizinga M; Trillo-Alvarez C; Papierniak ES
    J Asthma; 2021 Dec; 58(12):1670-1674. PubMed ID: 32962463
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Adalimumab-induced myasthenia gravis: case-based review.
    Pelechas E; Memi T; Markatseli TE; Voulgari PV; Drosos AA
    Rheumatol Int; 2020 Nov; 40(11):1891-1894. PubMed ID: 32322981
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Acetylcholine receptor antibody characteristics in myasthenia gravis. II. Patients with penicillamine-induced myasthenia or idiopathic myasthenia of recent onset.
    Vincent A; Newsom-Davis J
    Clin Exp Immunol; 1982 Aug; 49(2):266-72. PubMed ID: 7127905
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rheumatoid arthritis and ocular myasthenia gravis: Effectiveness of rituximab in the management of these two diseases.
    Novella-Navarro M; Salvatierra-Ossorio J; Muñoz-Gómez MDM; Pavo-Blanco M
    Reumatol Clin (Engl Ed); 2018; 14(3):179-180. PubMed ID: 28624374
    [No Abstract]   [Full Text] [Related]  

  • 13. Development of generalized disease at 2 years in patients with ocular myasthenia gravis.
    Kupersmith MJ; Latkany R; Homel P
    Arch Neurol; 2003 Feb; 60(2):243-8. PubMed ID: 12580710
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Efficacy and safety of ustekinumab in psoriatic arthritis after anti-TNFα failure in routine practice].
    Michel M; Reguiai Z; Fauconier M; Brochot P; Eschard JP; Salmon JH
    Therapie; 2016 Jun; 71(3):281-6. PubMed ID: 27235651
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Two cases of thymoma-associated myasthenia gravis without antibodies to the acetylcholine receptor.
    Maggi L; Andreetta F; Antozzi C; Confalonieri P; Cornelio F; Scaioli V; Mantegazza R
    Neuromuscul Disord; 2008 Aug; 18(8):678-80. PubMed ID: 18657424
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Anti-MuSK- and anti-AChR-positive myasthenia gravis induced by d-penicillamine.
    Poulas K; Koutsouraki E; Kordas G; Kokla A; Tzartos SJ
    J Neuroimmunol; 2012 Sep; 250(1-2):94-8. PubMed ID: 22683336
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [Anti-MuSK antibody positive myasthenia gravis with HIV infection successfully treated with cyclosporin: a case report].
    Kurokawa T; Nishiyama T; Yamamoto R; Kishida H; Hakii Y; Kuroiwa Y
    Rinsho Shinkeigaku; 2008 Sep; 48(9):666-9. PubMed ID: 19048951
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Stroke under treatment with ustekinumab for psoriatic arthritis.
    Aboudiab M; Andréjak M; Husein T; Goëb V
    Rev Neurol (Paris); 2019 Apr; 175(4):271-272. PubMed ID: 30638925
    [No Abstract]   [Full Text] [Related]  

  • 19. [Follow-up and immunologic findings in drug-induced myasthenia].
    Brüggemann W; Herath H; Ferbert A
    Med Klin (Munich); 1996 May; 91(5):268-71. PubMed ID: 8709903
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [D-penicillamine-induced myasthenia gravis].
    Frey RA; Keller F; Michel BA
    Schweiz Med Wochenschr; 1994 May; 124(20):852-6. PubMed ID: 8209208
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.